Azelis Group
F:2R7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Azelis Group
F:2R7
|
BE |
|
B
|
Brookdale Senior Living Inc
F:B7S
|
US |
|
I
|
IQE PLC
OTC:IQEPF
|
UK |
|
C
|
Corbus Pharmaceuticals Holdings Inc
F:337
|
US |
Wall St Price Targets
2R7 Price Targets Summary
Azelis Group
According to Wall Street analysts, the average 1-year price target for 2R7 is 14.16 EUR with a low forecast of 8.21 EUR and a high forecast of 18.21 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2R7's stock price target?
Price Target
14.16
EUR
According to Wall Street analysts, the average 1-year price target for 2R7 is 14.16 EUR with a low forecast of 8.21 EUR and a high forecast of 18.21 EUR.
What is the Revenue forecast for Azelis Group?
Projected CAGR
3%
Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Azelis Group?
Projected CAGR
4%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Azelis Group?
Projected CAGR
8%
Over the last 6 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Azelis Group?
Projected CAGR
14%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Azelis Group?
Projected CAGR
25%
Over the last 6 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 25%.
